Andreas Laustsen

Andreas Laustsen

Andreas Hougaard Laustsen, aka. Snakebite Jesus, is specialized in antibody discovery and toxicovenomics for rational development of antivenoms against snakebite. Andreas holds an M.Sc.Eng in Pharmaceutical Engineering from the Technical University of Denmark and a PhD in Molecular and Cellular Pharmacology from the University of Copenhagen. Currently, he is a Postdoctoral Fellow at the Technical University of Denmark, where he is working on developing the world’s first human oligoclonal recombinant antivenom against the venom of the notorious Black mamba from Africa. Andreas is a co-founder of the biotech companies Biosyntia (synthetic biology and metabolic engineering) and VenomAb (snakebite antivenom), and he is a founder and former Vice President of the entrepreneurship network REBBLS. Andreas has lived in the US, Australia, Paris, Cambridge, and Costa Rica, and in his spare time he likes traveling, reading, mountain climbing, and enjoying a glas of red wine, while looking out on the African savanna. Andreas is recognized as Denmark’s Coolest Engineer and writes a science blog for the newspaper, Ingeniøren.

Linkedin Profile